Endoradiotherapy in cancer treatment — Basic concepts and future trends

This publication has 63 references indexed in Scilit:

• Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma
  Nuclear Medicine and Biology, 2008
• Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design
  Biochemical Journal, 2006
• Preclinical Evaluation of the Breast Cancer Cell-Binding Peptide, p160
  Clinical Cancer Research, 2005
• Radiohalogens for imaging and therapy
  Chemical Society Reviews, 2004
• Thyroidal uptake and radiation dose after repetitive I‐131‐MIBG treatments: Influence of potassium iodide for thyroid blocking
  Medical and Pediatric Oncology, 2001
• Correlation of marrow dose estimates based on serial pretreatment radiopharmaceutical imaging and blood data with actual marrow toxicity in anti-CD20 yttrium-90 monoclonal antibody radioimmunotherapy of non-Hodgkinʼs B-cell lymphoma
  Nuclear Medicine Communications, 2001
• The Development of a [211At]-Astatinated Endoradiotherapeutic Drug: Part IV—Late Radiation Effects
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
• N,N′-Ethylene-di-l-Cysteine (EC) complexes of Ga(III) and In(III): Molecular modeling, thermodynamic stability and in vivo studies
  Nuclear Medicine and Biology, 1995
• In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats
  Life Sciences, 1991
• 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters
  Nature, 1977